Lookers (LOOK); reports positive trading for Q1 2019
On a like-for-like (LFL) basis, both turnover and gross profit for new cars were maintained at levels similar to last year
Lookers provided its trading update for the three months ended 31 March 2019. The turnover of new cars and used cars increased by 3% and 8%, respectively. Total gross profit from new cars rose 4% with a modest increase in profit per unit, while gross profit from used cars increased 2% (vs. previous year) with profit per unit maintained at previous levels.
Read more...Stride Gaming (STR); report net gaming revenue stood at £39.0m
Profit after tax and discontinued operations grew by 19.1% to 1.7m
Stride Gaming announced its interim results for the six months ended 28 February 2019. The group’s adjusted EBITDA stood at £6.2m for the period and gross cash of £21.9m was reported.
Read more...Metals Exploration (MTL); reports operating loss of $18.8m for FY 2018
Metals Exploration today posted its final results for the year ended 31 December 2018. The company reported an after tax loss of $176.4m. Total debt, excluding unpaid interest/fees and cash, stood at $103.2m and $1.5m respectively as of 31 December 2018.
Read more...De La Rue (DLAR); revenue grew 12% to £516.6m for FY 2019
De La Rue announced its full year results for the 12 months ended 30 March 2019, reporting that group’s adjusted operating profit was up 6% to £60.1m and basic adjusted EPS, excluding paper, increased 12% to 42.9p (2018: 38.2p).
Read more...BioPharma Credit (BPCR); announces new investment in a specialty pharma company
Investments comprise $80m of secured loans and $25m of equity
BioPharma Credit agreed to advance up to $80m as senior secured term loan with BioDelivery Sciences International (BDSI), a commercial-stage specialty pharmaceutical company. It also acquired a further 5m shares of BDSI at $5.00 each for a total cost of $25m in a public offering that was priced on 11 April 2019.
Read more...HarbourVest Global Priv. Equity Ltd (HVPE); NAV grew 12.3% to $24.09 for FY19
NAV per share return outperforms benchmark by 19.4% for the year
HarbourVest Global Private Equity Limited announced its results for the year ended 31 January 2019. NAV per share outperformed its benchmark FTSE All-World Total Return Index by 3.8% annually since inception in 2007. It also recorded annual compound growth of 12.2% over the past decade.
Read more...Telford Homes (TEF); announces total revenue up 12% to £354.3m
Profit before tax expectations for FY20 remain unchanged
Telford Homes announced its final results for the year ended 31 March 2019. The group’s total profit before tax fell to £40.1m (2018: £46.0m), owing to the increased proportion of lower-margin build to rent developments within the company’s total revenue.
Read more...Oxford Biomedica (OXB); announces strategic investment of up to £53.5m by Novo Holdings A/S
Under the subscription agreement, Novo Holdings agreed to subscribe for 6,568,024 new ordinary shares
Oxford Biomedica (OXB) announced Novo Holdings A/S agreed to invest up to £53.5m in the company in return for new ordinary shares, representing up to 10.1% of OXB’s outstanding shares after the capital increase. The proceeds from the transaction will be used to repay the existing debt facility with Oaktree Capital Management in full and further develop the LentiVector® platform and the proprietary product portfolio.
Read more...Avanti Communications Group (AVN); closes $55.0m 1.5 lien credit facility
The 1.5 facility ranks senior in relation to the company's high yield notes and junior in relation to the company's existing super senior debt
Avanti Communications Group announced the closure of its new $55.0m two-year 1.5 lien credit facility. The 1.5 facility matures in May 2021 or, if the company’s existing super senior facility is extended, in July 2021. Loans made under the 1.5 facility will bear PIK interest at an annual rate equal to 12.50%.
Read more...Oxford Biodynamics (OBD); posts revenue of £0.6m for H1 2019
The group remains well funded to continue its near-term plans
Oxford Biodynamics announced its interim results for the six-month period to 31 March 2019. It reported an operating loss of £1.7m (H1 2018: £1.3m) and a loss per share for the six months ended 31 March 2019 of 1.4p.
Read more...